Applications of 4-Amino-2-Chloro-5-Fluoropyrimidine in Industrial Manufacturing

4-Amino-2-Chloro-5-Fluoropyrimidine serves as a key intermediate in several advanced chemical synthesis routes. As a manufacturer, we support established global clients operating in regulated sectors that require reliable input for their production of pharmaceuticals, agrochemicals, and specialty pigments. Our material integrates directly into critical synthesis steps, allowing precise control over product output and ensuring full material traceability for downstream compliance audits.

1. Active Pharmaceutical Ingredient (API) Synthesis

Global pharmaceutical companies use this pyrimidine derivative as a building block for next-generation APIs, especially within antiviral, anti-tumor, and CNS-focused therapies. We deliver controlled lots, ensuring batch-to-batch consistency and compliance with ICH quality requirements. The compound enters multi-step synthesis routes for heterocycle expansion, facilitating introduction of fluorine and amine functionalities essential to the activity of final drug substances. Each batch undergoes rigorous impurity profile characterization, supporting clients’ registration dossiers in regulated markets.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for APIs
• United States Pharmacopeia (USP) General Chapter <823>
• European Pharmacopoeia (Ph. Eur.) monographs on intermediates
• FDA Guidance for Industry: Quality of APIs

Typical usage ratio

• Used at 0.2–2.5 molar equivalents based on final API synthetic route
• Adjusted for target moiety loading and impurity specifications
• Ratio confirmed during pilot and scale-up for regulatory filings
• Excess amounts minimized to comply with impurity limits

Downstream process integration

• Introduced in early to mid-stage heterocyclic ring construction
• Reacts under nucleophilic substitution or amination steps
• Followed by fluorination, chlorination, or coupling as required
• Spent reactants monitored to prevent carryover into API crystallization

Final product types

• Antiviral drug substances (e.g., nucleoside analogues)
• Oncology-targeting small molecule APIs
• CNS active pharmaceutical ingredients
• Experimental drugs and clinical trial materials

2. Crop Protection Actives Production

Agrochemical formulators employ this compound in the synthesis of active ingredients for modern herbicides and fungicides. Our high-purity offering allows for efficient conversion in multi-step processes that demand precise substitution patterns for the pyrimidine core. The active material’s fluorine and chlorine groups promote desired biological activity, while controlled amine substitution leads to effective final actives. We collaborate on production routes compliant with pesticide-specific toxicological and residual regulations, especially for export to high-standard regulatory jurisdictions.

Industry compliance standards

• FAO/WHO Specifications and Evaluations for Plant Protection Products
• REACH Registration for EU agrochemicals
• OECD Guidelines for the Testing of Chemicals
• EPA 40 CFR part 180 (Tolerances and Exemptions for Pesticide Chemicals in Food)

Typical usage ratio

• 1.0 molar equivalent in most core scaffold constructions
• Adjusted 0.6–1.2 times for process optimization based on downstream reactivity
• Losses tracked for environmental residue reporting
• Ratio set according to target minimum purity of synthesis output (>98%)

Downstream process integration

• Added in primary or secondary ring-substitution reactions
• Converted through amination, coupling, and halogen-exchange pathways
• Intermediate subjected to further chlorination or alkylation for desired actives
• Residues quantified per OECD and FAO standards before formulation

Final product types

• Systemic herbicides for broadleaf control
• Pyrimidine-based fungicides for cereal crops
• Seed treatment actives
• Pre-emergence anti-weed actives

3. Fluorinated Specialty Pigments Manufacturing

The pigment and dye industry uses this fluoropyrimidine compound to introduce unique color properties and enhance photostability in specialty pigments. Downstream customers rely on our product’s dual halogen and amine substitutions to tailor electronic absorption characteristics. The ingredient enters condensation or ring-closure syntheses, enabling production of pigments resistant to UV degradation and chemical bleaching. Consignment lots meet demanding batch color index and heavy metal release requirements essential for high-performance applications.

Industry compliance standards

• ETAD (Ecological and Toxicological Association of Dyes and Pigments Manufacturers) Guidelines
• EU REACH Substance Evaluation for Pigment Raw Materials
• ISO 12301 for Pigment Purity and Color Index Certification
• RoHS Directive 2011/65/EU for restricted substance content

Typical usage ratio

• 0.5–1.5 molar parts relative to core pigment backbone
• Adjusted based on color intensity requirements
• Lower ratios for effect pigments with high luster or stability focus
• Excess reactant levels minimized for regulatory and cost efficiency

Downstream process integration

• Integrated in condensation or cyclization reactions
• Used as a key input for specialty pigment ring systems
• Intermediates washed and filtered according to ETAD protocols
• Final pigments tested for shade, migration, and heavy metal leaching properties

Final product types

• High-performance inks for security printing
• Green and blue fluorinated dyes for electronics
• Specialty pigments for paints and protective coatings
• UV-resistant colorants for plastics and fibers

4. Veterinary Pharmaceutical Intermediate

Manufacturers of veterinary drugs deploy this chemical in targeted small molecule development, especially for livestock and companion animal therapies. The compound’s defined substitution pattern supports synthesis of actives requiring fluorination on the pyrimidine ring. We supply material tested to standards for veterinary use, with full compliance confirmation. Our support for GMP batch manufacturing ensures traceability and documentation suitable for regulatory submissions in animal health markets.

Industry compliance standards

• VICH GLs (International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products)
• EU GMP Part II for Veterinary Active Substances
• Chinese Veterinary Pharmacopoeia standards
• 21 CFR 514 US FDA requirements for veterinary drug intermediates

Typical usage ratio

• 0.8–2.0 molar equivalents based on target veterinary API
• Adjusted via route development for optimal yield and purity
• Low residual starting material permitted by pharmacopeia monographs
• Usage validated in pilot scale lots for target substance documentation

Downstream process integration

• Utilized in amination and halogenation steps for veterinary actives
• Integrated before chiral induction when needed
• Final step purification aligned with veterinary GMP procedures
• Residual analysis meets VICH guidelines for safety

Final product types

• Livestock feed additive APIs
• Parasiticide agents for companion animals
• Antimicrobial veterinary actives
• Medicated premix pharmaceutical intermediates